Ani Pharmaceuticals, Inc. (BSFA)
XSTU
Real-time Data
06:00 AM
Day's Range
63.0052 wk Range
59.50Overview - BSFA - Ani Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
1.44B
P/E (Trailing)
‪16.20‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪1.52‬
Price / Book
‪2.67‬
EV / EBITDA
‪7.84‬
Profitability
Gross Margin
‪62.35%‬
Profit Margin
‪11.07%‬
Operating Margin
‪14.97%‬
Return on Assets
‪5.44%‬
Return on Equity
‪20.45%‬
Ownership
Shares Outstanding
22.97M
Float
19.65M
Held by Insiders
‪5.41%‬
Held by Institutions
‪107.06%‬
Price stats
Beta
‪0.45‬
50-Day Avg
‪65.45‬
200-Day Avg
‪67.37‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BSFA - Ani Pharmaceuticals, Inc.
Peers - BSFA - Ani Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XSTU.
- BSFAXSTUAni Pharmaceuticals, Inc.1.49BMarket Cap-19.23%52-week change16.21P/E (Trailing)‪11.07%‬Profit Margin
- H6DXSTUHaleon Plc ADR72.13BMarket Cap+6.83%52-week change21.81P/E (Trailing)‪64.18%‬Profit Margin
- MRKCXSTUMerck KGaA – Sponsored ADR57.82BMarket Cap+21.80%52-week change24.40P/E (Trailing)‪11.21%‬Profit Margin
- D8Y0XSTUSandoz Group AG ADR32.45BMarket Cap+34.57%52-week change56.59P/E (Trailing)‪5.53%‬Profit Margin
- 08HHXSTUShanghai Fosun Pharmaceutical Group Co., Ltd.5.18BMarket Cap-37.45%52-week change11.43P/E (Trailing)‪7.96%‬Profit Margin
- 41LXSTULaboratorios Farmacéuticos Rovi SA4.08BMarket Cap-5.65%52-week change117.59P/E (Trailing)‪64.92%‬Profit Margin
- HM6AXSTUHypera S.A. Sponsored ADR2.80BMarket Cap+16.50%52-week change8.84P/E (Trailing)‪19.82%‬Profit Margin
Profile Summary - BSFA - Ani Pharmaceuticals, Inc.
About
ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and commercializes branded, generic, and specialty prescription medicines. ANI Pharmaceuticals focuses on three main areas: Rare Disease, Generics, and Established Brands. Its portfolio includes therapies for ophthalmology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
